The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial Function - Trial NCT05941910
Access comprehensive clinical trial information for NCT05941910 through Pure Global AI's free database. This Phase 2 trial is sponsored by Attikon Hospital and is currently Recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Attikon Hospital
Timeline & Enrollment
Phase 2
Apr 01, 2023
Dec 31, 2023
Primary Outcome
The effect of Q10 on Left Ventricular Myocardial Function
Summary
Non-alcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular risk.
 The aim of this study is to investigate the effects of coenzyme Q10 (CoQ10) on endothelial,
 vascular and myocardial function in patients with NAFLD
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05941910
Non-Device Trial